Nitrates for the prevention of cardiac morbidity and mortality in patients undergoing non-cardiac surgery

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 8, 2013, Pages

  Zhao, Na ^a   Xu, Jin ^a   Singh, Balwinder ^b   Wu, Taixiang ^c   Yu, Xuerong ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b Mayo Clinic   (United States)

^c SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; ISOSORBIDE MONONITRATE; PENTAERYTHRITYL TETRANITRATE; TROPONIN;

ACUTE HEART FAILURE; ANGINA PECTORIS; ARTICLE; GLAUCOMA; HEART ARREST; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART SURGERY; HUMAN; HYPERTENSION; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; HYPOTENSION; INTENTION TO TREAT ANALYSIS; LUNG EDEMA; LUNG VASCULAR RESISTANCE; MORBIDITY; MORTALITY; NON CARDIAC SURGERY; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; ST SEGMENT; SYSTEMATIC REVIEW;

EID: 85041516483     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD010726     Document Type: Article

References (46)

1. Abrams J. Glyceryl trinitrate (nitroglycerin) and the organic nitrates. Choosing the method of administration. Drugs 1987;34:391-403. [MEDLINE: 3119308]
2. Abrams J. Mechanisms of action of the organic nitrates in the treatment of myocardial ischemia. American Journal of Cardiology 1992;70:30B-42B. [MEDLINE: 1529924]
3. American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery), American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society for Vascular Surgery, Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, et al.ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Anesthesia and Analgesia 2008;106(3):685-712. [MEDLINE: 18292406]
4. Bassenge E. Coronary vasomotor responses: role of endothelium and nitrovasodilator. Cardiovascular Drugs and Therapy 1994;8:601-10. [MEDLINE: 7531489]
5. Battock DJ, Levitt PW, Steele PP. Effects of isosorbide dinitrate and nitroglycerin on central circulatory dynamics in coronary artery disease. American Heart Journal 1976;92:455-8. [MEDLINE: 822703]
6. Bogaert MG. Organic nitrates in angina pectoris. Archives Internationales de Pharmacodynamie et de Therapie 1972;196 Suppl:125. [MEDLINE: 4626390]
7. Brunton TL. On the use of nitrite of amyl in angina pectoris. Lancet 1867;90(2291):97-8.
8. Bundgaard H, Boesgaard S, Mortensen SA, Arendrup H, Aldershvile J. Effect of nitroglycerin in patients with increased pulmonary vascular resistance undergoing cardiac transplantation. Scandinavian Cardiovascular Journal 1997;31:339-42. [MEDLINE: 9455782]
9. Calderone A, Thaik CM, Takahashi N, Chang DL, Colucci WS. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. Journal of Clinical Investigation 1998;101:812-8. [MEDLINE: 9466976]
10. Cohen J. A coefficient of agreement for nominal scales. Educational and Psychological Measurement 1960;20:37-46.
11. Diodati J, Theroux P, Latour JG, Lacoste L, Lam JY, Waters D. Effects of nitroglycerin at therapeutic doses on platelet aggregation in unstable angina pectoris and acute myocardial infarction. American Journal of Cardiology 1990;66:683-8. [MEDLINE: 2119139]
12. Egger M, Smith GD, Phillips AN. Meta-analysis: principles and procedures. BMJ 1997;315(7121):1533-7. [MEDLINE: 9432252]
13. Fahmy NR. Nitroglycerin as a hypotensive drug during general anesthesia. Anesthesiology 1978;49:17-20. [MEDLINE: 96706]
14. Fleisher LA, Eagle KA. Clinical practice. Lowering cardiac risk in noncardiac surgery. The New England Journal of Medicine 2001;345:1677-82. [MEDLINE: 11759647]
15. Fremont RE. The actions of organic nitrates on the cardiopulmonary and peripheral circulations. Angiology 1961;12:391-400. [MEDLINE: 13701721]
16. Fung HL, Chung SJ, Bauer JA, Chong S, Kowaluk EA. Biochemical mechanism of organic nitrate action. American Journal of Cardiology 1992;70:4B-10B. [MEDLINE: 1529925]
17. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8- bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. Journal of Clinical Investigation 1989;83:1774-7. [MEDLINE: 2540223]
18. Gilbert K, Larocque BJ, Patrick LT. Prospective evaluation of cardiac risk indices for patients undergoing noncardiac surgery. Annals of Internal Medicine 2000;133:356-9. [MEDLINE: 10979880]
19. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schünemann HJ. What is "quality of evidence" and why is it important to clinicians. BMJ 2008;336:995-8. [MEDLINE: 18456631]
20. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21(11):1539-58.
21. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
22. Hoeks SE, Poldermans D. European Society of Cardiology 2009 guidelines for preoperative cardiac risk assessment and perioperative cardiac management in noncardiac surgery: key messages for clinical practice. Polish Archives of Internal Medicine 2010;120(7-8):294-9. [MEDLINE: 20693961]
23. Ignarro LJ, Napoli C, Loscalzo J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circulation Research 2002;90:21-8. [MEDLINE: 11786514]
24. JCS Joint Working Group. Guidelines for perioperative cardiovascular evaluation and management for noncardiac surgery (JCS 2008)--digest version. Circulation Journal 2011;75(4):989-1009. [MEDLINE: 21427501]
25. Johnson JB, Fairley A, Carter C. Effects of sublingual nitroglycerin on pulmonary arterial pressure in patients with left ventricular failure. Annals of Internal Medicine 1959;50:34-42. [MEDLINE: 13617828]
26. Kakisis JD, Abir F, Liapis CD, Sumpio BE. An appraisal of different cardiac risk reduction strategies in vascular surgery patients. The European Journal of Vascular and Endovascular Surgery 2003;25:493-504. [MEDLINE: 12787690]
27. Kaplan JA, Dunbar RW, Jones EL. Nitroglycerin infusion during coronary-artery surgery. Anesthesiology 1976;45:14-21. [MEDLINE: 820217]
28. Loscalzo J. Antiplatelet and antithrombotic effects of organic nitrates. American Journal of Cardiology 1992;70:18B-22B. [MEDLINE: 1529922]
29. Mangano DT. Perioperative cardiac morbidity. Anesthesiology 1990;72:153-84. [MEDLINE: 2404426]
30. Mangano DT, Browner WS, Hollenberg M, London MJ, Tubau JF, Tateo IM. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. The New England Journal of Medicine 1990;323(26):1781-8. [PUBMED: 2247116]
31. Mangano DT, Hollenberg M, Fegert G, Meyer ML, London MJ, Tubau JF, et al.Perioperative myocardial ischemia in patients undergoing noncardiac surgery: incidence and severity during the 4-day perioperative period. Journal of the American College of Cardiology 1991;17:843-50. [MEDLINE: 1999618]
32. Mangano DT, Goldman L. Preoperative assessment of patients with known or suspected coronary disease. The New England Journal of Medicine 1995;333:1750-6. [MEDLINE: 7491140]
33. Miller MR, Wadsworth RM. Understanding organic nitrates - a vein hope?. British Journal of Pharmacology 2009;157(4):565-7. [MEDLINE: 19630835]
34. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349:1498-504. [MEDLINE: 9167458]
35. Murrell W. Nitro-glycerine as a remedy for angina pectoris. Lancet 1879;113(2891):113-5.
36. Nossaman VE, Nossaman BD, Kadowitz PJ. Nitrates and nitrites in the treatment of ischemic cardiac disease. Cardiology in Review 2010;18(4):190-7. [MEDLINE: 20539102]
37. Palevsky HI, Fishman AP. Vasodilator therapy for primary pulmonary hypertension. Annual Review of Medicine 1985;26:563-78. [MEDLINE: 2859832]
38. Parker JA. Organic nitrates: new formulations and their clinical advantages. American Journal of Cardiology 1966;77:38C-40C. [MEDLINE: 8638525]
39. Pearlman AS, Engler RL, Goldstein RA, Kent KM, Epstein SE. Relative effects of nitroglycerin and nitroprusside during experimental acute myocardial ischemia. European Journal of Cardiology 1980;11:295-313. [MEDLINE: 6771145]
40. Rasch DK, Lancaster L. Successful use of nitroglycerin to treat postoperative pulmonary hypertension. Critical Care Medicine 1987;15:616-7. [MEDLINE: 2952462]
41. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
42. Sear JW, Higham H. Issues in the perioperative management of the elderly patient with cardiovascular disease. Drugs and Aging 2002;19:429-51. [MEDLINE: 12149050]
43. Silber S. Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate. European Journal of Clinical Pharmacology 1990;38 Suppl 1:S35-51. [MEDLINE: 2113003]
44. Stevens RD, Burri H, Tramer MR. Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesthesia and Analgesia 2003;97:623-33. [MEDLINE: 12933373]
45. Torfgard KE, Ahlner J. Mechanisms of action of nitrates. Cardiovascular Drugs and Therapy 1994;8:701-17. [MEDLINE: 7873467]
46. Yach D, Hawkes C, Gould CL, Hofman KJ. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA 2004;291:2616-22. [MEDLINE: 15173153]